Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
56.00    -1.00 (-1.75%)
Bid:
56.00
Ask:
56.00
Spread: 0.00 (0.00%)
Market Cap: £8.52m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

AIM Rule 17 Schedule Two (g) update

20 Jan 2025 13:30

RNS Number : 9939T
Transense Technologies PLC
20 January 2025
 

20 January 2025

 

Transense Technologies plc

("Transense" or the "Company")

 

AIM Rule 17 Schedule Two (g) update

 

Transense Technologies Plc (AIM: TRT), the provider of specialist sensing solutions and measurement systems, announces the following information relating to directors' disclosures under Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

 

Nigel Rogers, Chairman of Transense, was previously a director of TT Electronics Wireless Devices Limited (previously known as Hale End 999 Ltd) until 30 April 2011. Craig Wilson, Non-Executive Director, was a director of Williams Advanced Engineering Deutschland (GmbH) until January 2024. Craig Wilson was also a director of 01194903 Limited (also known as T.W.R. Group Limited) which went into administrative receivership in February 2003.

 

For further information please visit www.transense.com or contact:

 

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Melvyn Segal (Chief Financial Officer)

Via Investor Relations

(see below)

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Stefano Aquilino / Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Investor Relations

Anice McNamee

Tel: +44 (0)1869 238380 investor.relations@transense.co.uk

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

 

· SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied, Airbus and several other confidential Tier One automotive, aerospace and industrial machinery suppliers.

 

· Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software.

 

In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030.

 

Find out more at: https://www.transense.com/

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNSEWFDSEISEEF
Date   Source Headline
13th May 20267:00 amRNSGrant of Options
6th May 20267:00 amRNS-RLaunch of high-pressure tyre inspection tool
27th Apr 20263:00 pmRNSDirector/PDMR Shareholding - acquisition of shares
24th Apr 20261:25 pmRNSDirector/PDMR Shareholding - acquisition of shares
22nd Apr 20267:00 amRNS-RSAWsense investment to accelerate scale-up
8th Apr 202612:06 pmRNSHolding(s) in Company
13th Mar 202611:12 amRNSDirector/PDMR Shareholding - acquisition of shares
13th Mar 202611:12 amRNSDirector/PDMR Shareholding - acquisition of shares
13th Mar 20267:00 amRNSAward of major APC-backed project with Cummins
13th Mar 20267:00 amRNSAward of major APC-backed project with Cummins
17th Feb 20267:00 amRNSInterim Results
11th Feb 202610:22 amRNSHolding(s) in Company
9th Feb 20264:49 pmRNSHolding(s) in Company
2nd Feb 202612:36 pmRNSHolding(s) in Company
30th Jan 20267:00 amRNSTrading update and notice of interim results
12th Dec 20257:00 amRNSHolding(s) in Company
26th Nov 20259:04 amRNSResult of AGM
25th Nov 20257:00 amRNSAGM Statement and Trading Update
4th Nov 20257:00 amRNS-RLaunch of Translogik TLGi Smart Tyre Inflator
29th Oct 20259:00 amRNSPosting of Annual Report & Notice of AGM
23rd Sep 20257:00 amRNSFinal Results
12th Sep 20257:00 amRNSNotice of Results
4th Sep 20257:00 amRNS-RProducts update
28th Jul 20253:20 pmRNSTR-1
21st Jul 20253:28 pmRNSDirector/PDMR Shareholding - acquisition of shares
17th Jul 20257:00 amRNSTrading Update
11th Jun 20255:45 pmRNSHolding(s) in Company
21st May 20253:52 pmRNSTR - 1
21st May 20257:00 amRNSDirector/PDMR Shareholding - acquisition of shares
20th May 20257:00 amRNSStrategic US Packaging Collaboration
7th Apr 20253:13 pmRNSHolding(s) in Company
27th Mar 20252:28 pmRNSHolding(s) in Company
21st Mar 202511:38 amRNSHolding(s) in Company
12th Mar 202510:28 amRNSHolding(s) in Company
12th Mar 20257:00 amRNSDirector/PDMR Shareholding - acquisition of shares
4th Mar 202512:26 pmRNSHolding(s) in Company
4th Mar 20257:00 amRNSDirector/PDMR shareholding - acquisition of shares
3rd Mar 20257:00 amRNS-RContract with Logistics UK
25th Feb 202512:02 pmRNSDirector/PDMR shareholding - acquisition of shares
18th Feb 20253:16 pmRNSDirector/PDMR shareholding – acquisition of shares
18th Feb 20257:00 amRNSInterim Results & Investor Presentation
14th Feb 20257:00 amRNSStrategic Partnership with Haltec Corporation
22nd Jan 20257:00 amRNSTrading Update
20th Jan 20251:30 pmRNSAIM Rule 17 Schedule Two (g) update
8th Jan 20251:52 pmRNSDirector/PDMR shareholding – acquisition of shares
17th Dec 20245:02 pmRNSHolding(s) in Company
4th Dec 202411:43 amRNSHolding(s) in Company
28th Nov 202411:24 amRNSHolding(s) in Company
27th Nov 20245:18 pmRNSResult of AGM
27th Nov 20247:00 amRNSAGM Statement and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.